(Q420685)

rasagiline (English)

https://www.parkinson.org.il/%D7%90%D7%96%D7%99%D7%9C%D7%A7%D7%98-%D7%A8%D7%A1%D7%92%D7%99%D7%9C%D7%99%D7%9F-%D7%9E%D7%96%D7%99%D7%9C%D7%90%D7%98-%D7%9E%D7%99%D7%93%D7%A2-%D7%9E%D7%93%D7%A2%D7%99-%D7%A2%D7%9C-%D7%94%D7%AA/

3 October 2016

discoverer or inventor

Moussa B. H. Youdim

1 reference

reference URL

stereoisomer of

N-Propargyl-1(S)-Aminoindan

2 references

based on heuristic

inferred from InChIKey

based on heuristic

inferred from InChI

chemical formula

C₁₂H₁₃N

1 reference

rasagiline (English)

19 November 2016

C#CCNC1CCC2=CC=CC=C12

1 reference

rasagiline (English)

19 November 2016

C#CCN[C@@H]1CCC2=CC=CC=C12

1 reference

https://www.whocc.no/atc_ddd_index/?code=N04BD02

rasagiline (English)

19 November 2016

1 milligram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

Rasagiline Ratiopharm

1 reference

European Medicines Agency product number

EMEA/H/C/003957

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003957/human_med_001836.jsp

World Health Organisation international non-proprietary name

22 March 2017

rasagiline (English)

1 reference

rasagiline (English)

medical condition treated

3 October 2016

Parkinson's disease

1 reference

Drug Indications Extracted from FAERS

significant drug interaction

2 October 2018

bupropion

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(R,R)-tramadol

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

muscle stiffness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

seizure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

palpitation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypertensive crisis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

headache disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levodopa

orthostatic hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6641

Australian pregnancy category B3

17 August 2016

route of administration

oral administration

0 references

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Rasagiline

last update

21 July 2017

subject has role

monoamine oxidase inhibitor

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

C031967

15 March 2018

neuroprotective agent

1 reference

InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1

Medical Subject Headings

15 March 2018

Rasagiline

0 references

Identifiers

InChI

1 reference

RUOKEQAAGRXIBM-GFCCVEGCSA-N

rasagiline (English)

19 November 2016

2 references

rasagiline (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

136236-51-6

2 references

RUOKEQAAGRXIBM-GFCCVEGCSA-N

rasagiline (English)

19 November 2016

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=136236-51-6

1 reference

Rasagiline (English)

19 November 2016

1 reference

rasagiline (English)

19 November 2016

Reaxys registry number

9194207

1 reference

rasagiline (English)

3 October 2016

mapping relation type

1 reference

RASAGILINE (English)

19 November 2016

1 reference

Hazardous Substances Data Bank

RASAGILINE (English)

19 November 2016

1 reference

1 reference

28 October 2019

RASAGILINE (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

ECHA Substance Infocard ID

0 references

1 reference

Guide to Pharmacology Ligand ID

Rasagiline (English)

publication date

17 November 2015

6641

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

6641

rasagiline (English)

19 November 2016

1 reference

Medical Subject Headings

14 March 2018

1 reference

rasagiline (English)

19 November 2016

1 reference

Rasagiline (English)

Human Metabolome Database ID

19 November 2016

HMDB0015454

1 reference

based on heuristic

inferred from InChIKey

1 reference

rasagiline (English)

MedlinePlus drug identifier

19 November 2016

a606017

0 references

PatientsLikeMe treatment ID

0 references

1 reference

rasagiline (English)

19 November 2016

0 references

1 reference

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

rasagiline (English)

3 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

UMLS CUI

C0525678

1 reference